• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/44

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

44 Cards in this Set

  • Front
  • Back
___ plays a key role in generation of the resting membrane potential, which influences many biologic functions.
Potassium
Describe (in order) the EKG abnormalities we see in a hyperkalemic state, starting with a normal EKG and normal potassium concentration.
1 - Normal EKG
2 - "Take your right hand and 'pinch' the T wave" (a T wave with a peak like a mountain)
3 - "Now take your left hand and smoosh the P wave flat." (flattened P wave)
4 - "Now move them apart" (QRS complex gets wider and wider from this point on as [K+] increases)
Surpluses or deficits of K+ predispose to ____ _______.
cardiac arrhythmias
Immediate/Short-Term/Quick changes in [K+] takes place via...
exchange with the intracellular fluid (translocation into cells)
Factors promoting K+ uptake into cells
- [K+]p
- insulin*** (usually give some glucose with it)
- epinepherine***
- metabolic alkalosis
- aldosterone
The major way [K+] gets into the cell is via...
Na+/K+ ATPase
With INORGANIC metabolic acidosis (HCO3- loss or HCl gain), H+ moves ___ of cells and K+ moves ___ cells.
H+ moves INTO; K+ moves OUT

Note: There is little shift in organic acidosis
In metabolic alkalosis, K+ moves ____ cells, and H+ moves ____ of cells.
K+ moves INTO; H+ moves OUT

Note: There is little shift in respiratory alkalosis
_______ are in charge of long-term potassium balance.
Kidneys (through increase/decrease of excretion)
Factors promoting K+ excretion
- Aldosterone***
- Distal flow of Na and water (providing Na for exchangers)
- Plasma potassium concentration
Virtually all regulation of K+ occurs in the _____.
CCD (Cortical collecting duct)
Events controlling K+ excretion have the greatest impact in the _____.
CCD (Cortical collecting duct)
hyper-_____ and hypo-_____ are two major stimuli for aldosterone release.
Hyperkalemia; Hypovolemia
Factors contributing to ACUTE hyperkalemia
- Increased load
- Impaired excretion
- Release from cells (metabolic acidosis, cell lysis, rhabdomyolysis, beta blockade, insulin deficiency, exercise)
Factors contributing to CHRONIC hyperkalemia
- Severe renal failure
- Hypoaldosteronism
- Decreased distal flow and subsequent Na delivery
- Drugs (K-sparing diuretics, NSAIDs, ACE inhibitors, trimethoprim)
T or F: A hyperkalemic patient usually has more than one reason for hyperkalemia
TRUE
Key questions in assessing the cause of a non-obvious case of hyper-/hypokalemia:
1*** - Urine [K+] . . . (Normal is 80. If healthy kidney, hypokalemia excretion will be around 20, and hyperkalemia will be around 200)

2 - Is the problem in cortical
collecting duct volume or [K+]?

3*** - Is aldosterone acting? (TTKG = ((U/P) for K+) / ((U/P) for Osm) . . . TTKG > 7 means aldo is acting and TTKG < 2 means aldo is NOT acting.)
Mechanism of K+ loss during vomiting
K+ is lost via the URINE due to alkalosis, and increase aldosterone stimulation from hypovolemia.
Correcting severe hypokalemia may need several hundred mmol of ___ given in the form of _____ unless the patient is acidemic.
K+; KCl
Licorice can cause an excess of ________ through the inhibition of _______.
aldosterone; 11-Beta Hydroxysteroid Dehydrogenase
Define primary hyperaldosteronism
problems with the adrenal glands themselves producing too much aldosterone - either from a tumor, or some idiopathic etiology.
Liddle syndrome
aldosterone gain of function through a mutation, causing HTN, hypokalemia, and metabolic alkalosis. Treat with amiloride.
Bartter and Gitelman Syndrome
- Bartter: mimics loop diuretics, HYPERcalciuria ("Barter with my parents to go on the loop-de-loop roller coaster")

- Gitelman: mimics thiazide diuretics, HYPOcalciuria

- Bartter occurs earlier in life ("Bartters in babies"), and Gitelman is more common overall.
All diuretics (except apironolactone) act on the ____-side of the nephron.
LUMINAL-side
All diuretics (except mannitol) get into the lumen via...
SECRETION into the proximal tubule.
Pharm: Mannitol

(MOA, Pharmacokinetics, Toxicity, Indications,Contraindications)
1) Mechanism of action
-osmotic diuretic, acts as an osmole, pulling fluid into the tubule.

2) Pharmacokinetics
-only given intravenously, t1/2 ~1 hr

3) Toxicity
-from increased plasma osmolality

4)Indications
-decrease CNS pressure

5)Contraindications
-CHF, renal failure
Pharm: Acetazolamide

(MOA, Pharmacokinetics, Toxicity, Indications,Contraindications)
1) MOA
- increase urinary bicarb, K+, and water excretion. (Won't work unless there's adequate biarb in the plamsa.)

2) Pharmacokinetics
- weak diuretic, t1/2 ~ 13 hrs

3) Toxicity
- metabolic acidosis from losing bibarb and hypokalemia

4) Indications
- Glaucoma, CNS pressure, altitude sickness, urine alkalinization

5) contraindications
- liver failure
Pharm: Loop diuretics (MOA)
Mechanism of action: Inhibition of Na/K/2Cl co-transporters (AKA "furosemide-sensitive transporters")
Pharm: Loop diuretics (Pharmacokinetics)
Fast - acts in 20 minutes. Most potent of the diuretics. t1/2 ~ 1-2 hrs.
Pharm: Loop diuretics (Toxicity)
- hypokalemia
- volume contraction
- Ca and Mg depletion
Pharm: Loop diuretics (Indications/Contraindications)
Indication: HTN, acute diuresis needed, need more potent diuretic, hypercalcemia

Contraindication: susceptible to vomune depletion (i.e. the elderly), susceptible to hypokalemia (digitalis, hepatic cirrhosis)
Pharm: Thiazide diuretics (MOA)
Mechanism of action: inhibits NaCl transport in the cortical thick ascending loop and distal tubule
Pharm: Thiazide diuretics (Pharmakokinetics)
well absorbed from gut, acts within 1 hr, lasts 6-48 HOURS

Note: these last longer than loop diuretics, thus, they're more likely to cause hypokalemia
Pharm: Thiazide diuretics (toxicity)
hypokalemia, hyponatremia, hyperuricemia, and hypercalcemia
Pharm: Metolazone
same MOA as thiazides; given in addition to loop diuretics sometimes for extra "punch"; often given in more advanced renal insufficiency
Pharm: K-Sparing Diuretics (MOA)

e.g. Spironolactone and Eplerenone
MOA: competitive aldosterone antagonist. Inhibits the reabsorption of Na as well as K+/H+ secretion in the late distal tubule and collecting duct.
Pharm: K-Sparing Diuretics (Pharmakokinetics)

e.g. Spironolactone and Eplerenone
Takes up to 2 days to start working; spironolactone is the only diuretic to work on the "blood" side of the tubule; relatively weak diuretic
Pharm: K-Sparing Diuretics (Toxicity)

e.g. Spironolactone and Eplerenone
- Hyperkalemia
- Gynecomastia, and amenorrhea (spironolactone)
Pharm: K-Sparing Diuretics (Indications/Contraindications)

e.g. Spironolactone and Eplerenone
Indications: Primary hyperaldosteronism, Secondary hyperaldosteronism (cirrhosis), Chronic heart failure (reduces mortality)

Contraindications: hyperkalemia
Pharm: amiloride (MOA)
K+ sparing diuretic (so don't give to a hyperkalemic patient), inhibits the Na+ channels in the late tubule and collecting duct, and since the positively-charge Na isn't reabsorbed, the positively-charge K+ doesn't move out into the lumen to take its place, thus, it's potassium-sparing.
Why don't diuretics work?
- failure to treat the underlying/primary disorder
- high Na intake
- noncompliance
- volume depletion
- NSAIDs (reducing renal blood flow)
- metabolic acidosis (lowers efficacy of carbonic anhydrase inhibitors)
The two main substances the kidney uses to "deal with" (excrete) acids
Ammonia (binds a H+ to turn into ammonium), Phosphate
How to use urinary Cl- to treat metabolic alkalosis
Urinary Cl- is < 10 = chloride RESPONSIVE = non-renal problem . . . give NaCl

Urinary Cl- is > 10 = chloride UNresponsive = kidney's fault . . . stop diuretics, and treat the problem.
Most important test to help you determine the cause of non-anion gap metabolic acidosis is:
Urinary anion gap
= urinary (Na + K) - Cl